Related Experiment Video
Updated: Jun 23, 2025

Simultaneous Electrical and Mechanical Stimulation to Enhance Cells' Cardiomyogenic Potential
Published on: January 18, 2019
Exploring Syndecan-4 and MLP and Their Interaction in Primary Cardiomyocytes and H9c2 Cells
Thea Parsberg Støle1, Marianne Lunde1,2, Katja Gehmlich3,4
1Institute for Experimental Medical Research, Oslo University Hospital and University of Oslo, 0450 Oslo, Norway.
Abstract:
The transmembrane proteoglycan syndecan-4 is known to be involved in the hypertrophic response to pressure overload. Although multiple downstream signaling pathways have been found to be involved in this response in a syndecan-4-dependent manner, there are likely more signaling components involved. As part of a larger syndecan-4 interactome screening, we have previously identified MLP as a binding partner to the cytoplasmic tail of syndecan-4. Interestingly, many human MLP mutations have been found in patients with hypertrophic (HCM) and dilated cardiomyopathy (DCM). To gain deeper insight into the role of the syndecan-4-MLP interaction and its potential involvement in MLP-associated cardiomyopathy, we have here investigated the syndecan-4-MLP interaction in primary adult rat cardiomyocytes and the H9c2 cell line. The binding of syndecan-4 and MLP was analyzed in total lysates and subcellular fractions of primary adult rat cardiomyocytes, and baseline and differentiated H9c2 cells by immunoprecipitation. MLP and syndecan-4 localization were determined by confocal microscopy, and MLP oligomerization was determined by immunoblotting under native conditions. Syndecan-4-MLP binding, as well as MLP self-association, were also analyzed by ELISA and peptide arrays. Our results showed that MLP-WT and syndecan-4 co-localized in many subcellular compartments; however, their binding was only detected in nuclear-enriched fractions of isolated adult cardiomyocytes. In vitro, syndecan-4 bound to MLP at three sites, and this binding was reduced in some HCM-associated MLP mutations. While MLP and syndecan-4 also co-localized in many subcellular fractions of H9c2 cells, these proteins did not bind at baseline or after differentiation into cardiomyocyte-resembling cells. Independently of syndecan-4, mutated MLP proteins had an altered subcellular localization in H9c2 cells, compared to MLP-WT. The DCM- and HCM-associated MLP mutations, W4R, L44P, C58G, R64C, Y66C, K69R, G72R, and Q91L, affected the oligomerization of MLP with an increase in monomeric at the expense of trimeric and tetrameric recombinant MLP protein. Lastly, two crucial sites for MLP self-association were identified, which were reduced in most MLP mutations. Our data indicate that the syndecan-4-MLP interaction was present in nuclear-enriched fractions of isolated adult cardiomyocytes and that this interaction was disrupted by some HCM-associated MLP mutations. MLP mutations were also linked to changes in MLP oligomerization and self-association, which may be essential for its interaction with syndecan-4 and a critical molecular mechanism of MLP-associated cardiomyopathy.
Insights
Syndecan-4 binds to MLP in heart cells, but this interaction is disrupted by mutations linked to cardiomyopathy. MLP mutations also alter its self-association, potentially causing heart disease.
Area of Science:
- Cardiovascular Biology
- Molecular Cardiology
- Cell Signaling
Background:
- Syndecan-4 (a transmembrane proteoglycan) is implicated in the heart's hypertrophic response to pressure overload.
- MLP (Muscle LIM Protein) mutations are found in human hypertrophic (HCM) and dilated cardiomyopathy (DCM).
- MLP has been identified as a binding partner to syndecan-4's cytoplasmic tail.
Purpose of the Study:
- To investigate the syndecan-4-MLP interaction in primary adult rat cardiomyocytes and H9c2 cells.
- To understand the role of this interaction in MLP-associated cardiomyopathy.
- To examine how MLP mutations affect its interaction with syndecan-4 and its oligomerization.
Main Methods:
- Immunoprecipitation to analyze syndecan-4 and MLP binding in cell lysates and subcellular fractions.
- Confocal microscopy for visualizing MLP and syndecan-4 localization.
- ELISA and peptide arrays to study syndecan-4-MLP binding and MLP self-association.
- Immunoblotting under native conditions to assess MLP oligomerization.
Main Results:
- Syndecan-4 and MLP co-localized in various cellular compartments, with binding detected specifically in nuclear-enriched fractions of adult cardiomyocytes.
- In vitro, syndecan-4 bound to MLP at three sites, with reduced binding observed for some HCM-associated MLP mutations.
- MLP mutations altered MLP oligomerization, increasing monomers at the expense of trimers and tetramers, and affected MLP self-association sites.
Conclusions:
- The syndecan-4-MLP interaction occurs in nuclear-enriched fractions of adult cardiomyocytes and is disrupted by certain HCM-associated MLP mutations.
- MLP mutations impact its oligomerization and self-association, suggesting a critical mechanism in MLP-associated cardiomyopathy.
- Further research into the syndecan-4-MLP interaction and MLP's structural changes is warranted for understanding cardiomyopathy pathogenesis.

